Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
NN-9441 by Inversago Pharma for Obesity: Likelihood of Approval
NN-9441 is under clinical development by Inversago Pharma and currently in Phase I for Obesity. According to GlobalData, Phase I...